Members‎ > ‎Opportunities‎ > ‎

NICE Guideline Smoking in Pregnancy

Representative Required - NICE Guideline Quitting Smoking in Pregnancy and Following Childbirth

About the Opportunity
The Young People's Health Special Interest Group have been invited to nominate someone to represent the College at an implementation planning meeting for this public health guidance. The meeting is due to take place in London on Tuesday 5 January, 2010.

The purpose of the meeting is for NICE to gain an understanding of relevant clinical issues and current policies that may impact on implementation. NICE are looking for individuals with knowledge and understanding of the systems and structures in place which could act as levers or barriers to implementation and who could contribute a national, high-level perspective on how these could be utilised or overcome.

Given the significance of this guidance in the field of children’s health, it is important that it is effectively implemented, and essential that paediatricians are able to contribute to its implementation. Continuing professional development (CPD) points are available for the time taken to attend the meeting and subsequently feed any issues back to the College.

How to Get Involved
The College is able to send one representative to this meeting. Should there be interest in attending from more than one person, it will be necessary to select the most suitable representative, based on criteria described on our website, www.rcpch.ac.uk/Research/CE/Get-involved/consultation-work-and-CPD

If you would like to nominate yourself or another person to represent the College at this meeting, please send us a personal statement, and return to us via email to clinical.effectiveness@rcpch.ac.uk by Friday 16 October. Please cover the following points:

  • Your affiliation to (or nomination from) a relevant College Specialty Advisory Committee (CSAC), specialty group or special interest group
  • Details of your interest and experience in this area, including clinical practice with relevant patient group(s), and any primary or secondary research you have had published in the field
  • Previous representation on a Guideline Development Group for a relevant topic
  • Any conflicts of interest you wish to declare

If you have any questions please contact the Clinical Effectiveness team. We thank you for your help in advance.

Dr Sabine Maguire - Quality of Practice Chair, RCPCH

Dr David Vickers - Registrar, RCPCH

Comments